Featured Products

My Quote Request

No products added yet

6505-01-363-0558

20 Products

NDC22170-0208-18

CETYLPYRIDINIUM CHLORIDE LOZENGES,USP

NSN, MFG P/N

6505013630558

NSN

6505-01-363-0558

View More Info

NDC22170-0208-18

CETYLPYRIDINIUM CHLORIDE LOZENGES,USP

NSN, MFG P/N

6505013630558

NSN

6505-01-363-0558

MFG

COMBE INCORPORATED

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETYLPYRIDINIUM CHLORIDE LOZENGES USP 432S PG
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 LOZENGES
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 2 STRIP
PRIMARY CONTAINER TYPE: STRIP
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 18 LOZENGES PER BOX; 24 BOXES PER PG
TOTAL PRIMARY CONTAINER QUANTITY: 24

LUPRON

LEUPROLIDE ACETATE INJECTION KIT

NSN, MFG P/N

6505013630935

NSN

6505-01-363-0935

View More Info

LUPRON

LEUPROLIDE ACETATE INJECTION KIT

NSN, MFG P/N

6505013630935

NSN

6505-01-363-0935

MFG

TAP PHARMACEUTICAL PRODUCTS INC

Description

(NON-CORE DATA) COMPONENT QUANTITY: 43
(NON-CORE DATA) NONSUPPLY ITEMS AND QUANTITIES: 2.8 ML. MILTI-DOSE VIAL 1; 0.5 ML. HYPODERMIC,DISPOSABLE SYRINGES 14; INDIVIDUALLY FOIL WRAPPED ALCOHOL WIPES 28
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML.
USAGE DESIGN: FOR USE IN THE TREATMENT OF PROSTATIC CANCER

NDC00300-3626-28

LEUPROLIDE ACETATE INJECTION KIT

NSN, MFG P/N

6505013630935

NSN

6505-01-363-0935

View More Info

NDC00300-3626-28

LEUPROLIDE ACETATE INJECTION KIT

NSN, MFG P/N

6505013630935

NSN

6505-01-363-0935

MFG

TAP PHARMACEUTICAL PRODUCTS INC

Description

(NON-CORE DATA) COMPONENT QUANTITY: 43
(NON-CORE DATA) NONSUPPLY ITEMS AND QUANTITIES: 2.8 ML. MILTI-DOSE VIAL 1; 0.5 ML. HYPODERMIC,DISPOSABLE SYRINGES 14; INDIVIDUALLY FOIL WRAPPED ALCOHOL WIPES 28
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML.
USAGE DESIGN: FOR USE IN THE TREATMENT OF PROSTATIC CANCER

A92G020

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

View More Info

A92G020

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

MFG

DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN INJECTION USP 1ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR PEDIATRIC USE
TOTAL PRIMARY CONTAINER QUANTITY: 10

LANOXIN

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

View More Info

LANOXIN

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

MFG

BURROUGHS WELLCOME CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN INJECTION USP 1ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR PEDIATRIC USE
TOTAL PRIMARY CONTAINER QUANTITY: 10

LANOXIN INJECTION

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

View More Info

LANOXIN INJECTION

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

MFG

BURROUGHS WELLCOME CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN INJECTION USP 1ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR PEDIATRIC USE
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00081-0262-10

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

View More Info

NDC00081-0262-10

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

MFG

BURROUGHS WELLCOME CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN INJECTION USP 1ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR PEDIATRIC USE
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00173-0262-10

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

View More Info

NDC00173-0262-10

DIGOXIN INJECTION,USP

NSN, MFG P/N

6505013631193

NSN

6505-01-363-1193

MFG

CARDINAL HEALTH INC. DBA CARDINAL HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN INJECTION USP 1ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR PEDIATRIC USE
TOTAL PRIMARY CONTAINER QUANTITY: 10

149112

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505013631636

NSN

6505-01-363-1636

View More Info

149112

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505013631636

NSN

6505-01-363-1636

MFG

LAFAYETTE PHARMACAL INC DIAGNOSTIC PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: LEMON AND VANILLA
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
SPECIAL FEATURES: DISPOSABLE
TOTAL PRIMARY CONTAINER QUANTITY: 36

NDC00024-1414-75

IOHEXOL INJECTION

NSN, MFG P/N

6505013631638

NSN

6505-01-363-1638

View More Info

NDC00024-1414-75

IOHEXOL INJECTION

NSN, MFG P/N

6505013631638

NSN

6505-01-363-1638

MFG

SANOFI-SYNTHELABO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS IOHEXOL PER MILLILITER
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: PRESERVATIVE FREE; SUBJECT TO DAMAGE BY FREEZING
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE

OMNIPAQUE 350

IOHEXOL INJECTION

NSN, MFG P/N

6505013631638

NSN

6505-01-363-1638

View More Info

OMNIPAQUE 350

IOHEXOL INJECTION

NSN, MFG P/N

6505013631638

NSN

6505-01-363-1638

MFG

SANOFI-SYNTHELABO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS IOHEXOL PER MILLILITER
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: PRESERVATIVE FREE; SUBJECT TO DAMAGE BY FREEZING
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE

CARDIZEM

DILTIAZEM TABLETS,USP

NSN, MFG P/N

6505013631639

NSN

6505-01-363-1639

View More Info

CARDIZEM

DILTIAZEM TABLETS,USP

NSN, MFG P/N

6505013631639

NSN

6505-01-363-1639

MFG

SANOFI-AVENTIS U.S. INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 90.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
COATING FEATURE: FILM, NONENTERIC
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE

NDC00088-1791-90

DILTIAZEM TABLETS,USP

NSN, MFG P/N

6505013631639

NSN

6505-01-363-1639

View More Info

NDC00088-1791-90

DILTIAZEM TABLETS,USP

NSN, MFG P/N

6505013631639

NSN

6505-01-363-1639

MFG

SANOFI-AVENTIS U.S. INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 90.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
COATING FEATURE: FILM, NONENTERIC
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE

EXCEL

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

View More Info

EXCEL

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

L6100

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

View More Info

L6100

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00264-7610-00

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

View More Info

NDC00264-7610-00

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013632964

NSN

6505-01-363-2964

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

5B4825

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013637652

NSN

6505-01-363-7652

View More Info

5B4825

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013637652

NSN

6505-01-363-7652

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE PER LITER AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 95.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND MAGNESIUM ION 0.500 MILLIEQUIVALENT PER LITER AND LACTATE
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: ION 40.000 MILLIEQUIVALENT PER LITER

NDC00536-5260-01

VITAMIN E CAPSULES,USP

NSN, MFG P/N

6505013637653

NSN

6505-01-363-7653

View More Info

NDC00536-5260-01

VITAMIN E CAPSULES,USP

NSN, MFG P/N

6505013637653

NSN

6505-01-363-7653

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 INTERNATIONAL UNITS VITAMIN E ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NATURAL; CONTAINS NO PRESERVATIVES

749887

TRICHLOROACETIC ACID,ACS

NSN, MFG P/N

6505013637674

NSN

6505-01-363-7674

View More Info

749887

TRICHLOROACETIC ACID,ACS

NSN, MFG P/N

6505013637674

NSN

6505-01-363-7674

MFG

AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE

Description

(NON-CORE DATA) UNIT PACKAGE QUANTITY: 1
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRICHLOROACETIC ACID ACS 15ML BOTTLE
PHYSICAL FORM: LIQUID
QUANTITY WITHIN EACH UNIT PACKAGE: 15.000 MILLILITERS
SPECIAL FEATURES: 80 PCT TRICHLORACETIC ACID

F92G645

TRICHLOROACETIC ACID,ACS

NSN, MFG P/N

6505013637674

NSN

6505-01-363-7674

View More Info

F92G645

TRICHLOROACETIC ACID,ACS

NSN, MFG P/N

6505013637674

NSN

6505-01-363-7674

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

(NON-CORE DATA) UNIT PACKAGE QUANTITY: 1
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRICHLOROACETIC ACID ACS 15ML BOTTLE
PHYSICAL FORM: LIQUID
QUANTITY WITHIN EACH UNIT PACKAGE: 15.000 MILLILITERS
SPECIAL FEATURES: 80 PCT TRICHLORACETIC ACID